June  Morris net worth and biography

June Morris Biography and Net Worth

Insider of Vicarious Surgical
Prior to joining Vicarious Surgical, Mr. Kelly served as Chief Financial Officer at Exosome Diagnostics, a privately held healthcare company focused on developing and commercializing revolutionary biofluid-based diagnostics, from 2014 to 2018. During his time at Exosome Diagnostics, he helped raise over $60 million and oversaw its transition to a commercial stage company with the successful launch of its first product, Exosome Prostate Intelliscore. In 2018, Mr. Kelly managed the negotiation and execution of the company's sale to Bio-Techne, Inc. for $575 million, including contingent.

Before joining Exosome Diagnostics, Inc., Mr. Kelly served as Chief Financial Officer of Repligen Corporation, a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems. While at Repligen Corporation, Mr. Kelly was responsible for all aspects of Repligen's finance, human resources, information technology and facilities operations and helped lead the company through its transition to a commercial bioprocessing enterprise driving growth of nearly ten times in market capitalization.

What is June Morris' net worth?

The estimated net worth of June Morris is at least $222,205.11 as of September 20th, 2023. Ms. Morris owns 19,339 shares of Vicarious Surgical stock worth more than $222,205 as of November 23rd. This net worth approximation does not reflect any other investments that Ms. Morris may own. Learn More about June Morris' net worth.

How do I contact June Morris?

The corporate mailing address for Ms. Morris and other Vicarious Surgical executives is 78 Fourth Avenue Waltham, MA 02451. Vicarious Surgical can also be reached via phone at 617 868 1700 and via email at [email protected]. Learn More on June Morris' contact information.

Has June Morris been buying or selling shares of Vicarious Surgical?

June Morris has not been actively trading shares of Vicarious Surgical during the last quarter. Most recently, June Morris sold 36 shares of the business's stock in a transaction on Wednesday, September 20th. The shares were sold at an average price of $23.70, for a transaction totalling $853.20. Following the completion of the sale, the insider now directly owns 19,339 shares of the company's stock, valued at $458,334.30. Learn More on June Morris' trading history.

Who are Vicarious Surgical's active insiders?

Vicarious Surgical's insider roster includes Sammy Khalifa (CTO), June Morris (Insider), and Adam Sachs (CEO). Learn More on Vicarious Surgical's active insiders.

Are insiders buying or selling shares of Vicarious Surgical?

During the last year, insiders at the sold shares 29 times. They sold a total of 9,517 shares worth more than $86,879.00. The most recent insider tranaction occured on November, 20th when CEO Adam David Sachs sold 817 shares worth more than $7,328.49. Insiders at Vicarious Surgical own 11.7% of the company. Learn More about insider trades at Vicarious Surgical.

Information on this page was last updated on 11/20/2024.

June Morris Insider Trading History at Vicarious Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/20/2023Sell36$23.70$853.2019,339View SEC Filing Icon  
9/5/2023Sell212$29.10$6,169.2019,375View SEC Filing Icon  
8/24/2023Sell83$28.50$2,365.5019,588View SEC Filing Icon  
8/21/2023Sell213$27.60$5,878.8019,672View SEC Filing Icon  
6/23/2023Sell70$57.60$4,032.0019,885View SEC Filing Icon  
6/20/2023Sell36$61.50$2,214.0019,956View SEC Filing Icon  
5/24/2023Sell83$69.30$5,751.909,976View SEC Filing Icon  
5/22/2023Sell213$67.50$14,377.5010,060View SEC Filing Icon  
3/22/2023Sell37$73.80$2,730.6010,343View SEC Filing Icon  
2/24/2023Sell83$84.30$6,996.9010,381View SEC Filing Icon  
2/21/2023Sell207$83.70$17,325.9010,464View SEC Filing Icon  
12/27/2022Sell71$53.10$3,770.1010,671View SEC Filing Icon  
12/20/2022Sell35$56.10$1,963.5010,743View SEC Filing Icon  
11/25/2022Sell83$110.70$9,188.1010,778View SEC Filing Icon  
11/21/2022Sell200$98.40$19,680.0010,862View SEC Filing Icon  
10/24/2022Sell83$94.20$7,818.6011,062View SEC Filing Icon  
9/27/2022Sell74$105.00$7,770.0011,146View SEC Filing Icon  
9/21/2022Sell32$116.70$3,734.4011,221View SEC Filing Icon  
8/29/2022Sell45$114.90$5,170.5011,300View SEC Filing Icon  
8/25/2022Sell33$123.90$4,088.7011,369View SEC Filing Icon  
8/23/2022Sell16$118.80$1,900.8011,428View SEC Filing Icon  
6/27/2022Sell75$108.30$8,122.5011,444View SEC Filing Icon  
6/21/2022Sell31$111.00$3,441.0011,520View SEC Filing Icon  
3/28/2022Sell76$123.30$9,370.80View SEC Filing Icon  
1/25/2022Sell73$161.10$11,760.30View SEC Filing Icon  
See Full Table

June Morris Buying and Selling Activity at Vicarious Surgical

This chart shows June Morris's buying and selling at Vicarious Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vicarious Surgical Company Overview

Vicarious Surgical logo
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $11.49
Low: $10.29
High: $11.60

50 Day Range

MA: $7.53
Low: $5.32
High: $11.49

2 Week Range

Now: $11.49
Low: $4.27
High: $21.43

Volume

37,807 shs

Average Volume

25,937 shs

Market Capitalization

$67.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02